Why Do You Go Bald on Top of Your Head?

Hair follicles on the crown and temples of your head carry far more androgen receptors than follicles at the back and sides, and that difference in receptor density is the core reason baldness strikes the top while leaving a horseshoe fringe intact. The hormone dihydrotestosterone, or DHT, binds to those receptors and gradually shrinks each follicle until it can no longer produce a visible hair. But receptor density alone doesn’t explain the full picture: developmental biology, mechanical forces, inflammation, blood supply, and the fate of stem cells all converge to make the top of your scalp uniquely vulnerable.

The Hormone That Shrinks Your Follicles

DHT is made from testosterone by an enzyme called 5-alpha reductase, which is active in many tissues throughout the body. In scalp skin, DHT binds to androgen receptors inside the dermal papilla cells at the base of each hair follicle. Once it binds, it triggers a cascade that progressively shortens the growth phase of the hair cycle and causes the follicle to miniaturize, producing thinner, shorter, lighter hairs with each successive cycle until the follicle eventually stops producing visible hair altogether.¹

This process is gradual. A healthy scalp hair spends years in the growth phase (called anagen), and only about nine percent of follicles are resting at any given time.² As DHT pushes more follicles out of growth and into rest prematurely, the ratio shifts. Hairs spend less time growing and more time dormant. Each new hair that emerges is a little finer than the last, a process called follicular miniaturization. Over years or decades, the affected follicles produce only wispy, nearly invisible “vellus” hairs instead of the thick terminal hairs you started with.

What makes this paradoxical is that DHT promotes hair growth in other parts of the body. The same hormone that thickens beard hair and chest hair is the one destroying scalp hair. The difference comes down to how each follicle’s dermal papilla cells are genetically programmed to respond to androgen signaling. Scalp follicles in susceptible zones interpret the signal as an instruction to shut down; follicles on the chin interpret the same signal as an instruction to grow.

Why the Crown and Temples, Not the Back

The reason baldness follows such a predictable geographic pattern on the scalp comes down to regional biology. Androgen receptor expression in the dermal papilla cells of frontal (top and temples) hair follicles is substantially higher than in occipital (back of the head) follicles. When researchers exposed frontal follicles to DHT, androgen receptor expression increased further, while occipital follicles showed much lower receptor levels to begin with and less response to the hormone.³ The back and sides of the scalp are, in essence, deaf to the hormonal signal that causes miniaturization. This is why hair transplant surgery works: follicles moved from the back of the head to the top retain their original low receptor profile and keep growing in their new location.

A deeper question is why the receptor density varies across the scalp in the first place. One explanation focuses on the developmental origins of scalp skin itself. The skin and the dermal cells that form hair follicles in different regions of the scalp arise from different embryonic tissue populations during fetal development. Researchers have proposed that these distinct developmental origins may wire certain scalp regions to be inherently more sensitive to androgens than others, essentially setting the pattern for baldness long before puberty.⁴ In this view, the balding pattern is not random or incidental; it reflects an ancient map of embryonic cell migration that determines which follicles will be androgen-sensitive adults.

The Tension Hypothesis

Hormones and receptor density aren’t the only proposed explanation for why baldness targets specific zones. A separate line of thinking points to the galea aponeurotica, the tough sheet of fibrous tissue that stretches across the top of the skull beneath the scalp. Unlike the sides and back of the head, which have thick muscle layers, the crown has this relatively rigid membrane. The scalp skin on top is fused to the galea, and as the muscles around it pull, the tissue on top experiences chronic low-grade mechanical tension.

Researchers have noted that the points of peak mechanical tension from the galea correspond closely to the places where hair loss begins. The hypothesis suggests that this tension activates specific molecular pathways in dermal papilla cells, including an androgen receptor coactivator that amplifies the response to DHT. In other words, the mechanical environment of the crown may prime follicles to be even more sensitive to androgen signaling than they would be based on receptor density alone.⁵ This remains a hypothesis rather than established fact, but it offers an intriguing mechanical complement to the hormonal story and could help explain why the very top of the head, where the galea is tautest, tends to thin before the frontal hairline in many men.

Inflammation and Scarring Around the Follicle

If you look at balding scalp under a microscope, you don’t just see shrunken follicles. You see an inflamed, scarred neighborhood. Studies consistently find perifollicular inflammation, meaning immune cells clustered around the upper portion of the follicle, in balding scalp tissue. One histological study found lymphocytes and mast cells surrounding the follicle’s upper structures, along with fibrosis (scarring) that progressively tightens the tissue around the follicle like a slowly closing fist.⁶

This fibrosis is not trivial. Comparative research has found that over sixty percent of balding scalp samples show perifollicular fibrosis, with scarring around the follicle’s isthmus (the narrowest part of its permanent structure) being particularly pronounced in androgenetic alopecia compared to other scalp conditions.⁷ The inflammation and fibrosis likely form a vicious cycle with hormonal miniaturization: DHT-driven changes provoke inflammation, inflammation drives scarring, and scarring physically constricts the follicle, making it harder for even a biologically viable follicle to produce a normal hair.

The scalp’s microbial community may also play a role in this inflammatory environment. A study of over a hundred men found that those with androgenetic alopecia had a measurably different scalp microbiome compared to men without hair loss, with an increased abundance of certain bacteria and shifts in sebum composition that could contribute to chronic low-grade scalp inflammation.⁸ Whether this dysbiosis is a cause or a consequence of hair loss is still being sorted out, but it adds another layer to the hostile local environment that follicles on the top of the head must contend with.

Blood Supply and the Growth Phase

Hair follicles are metabolically demanding structures, and their blood supply fluctuates dramatically with the hair cycle. During the growth phase, follicles upregulate a signaling molecule called VEGF, which triggers a burst of new blood vessel formation around each follicle. This enhanced blood supply is critical: experiments in mice showed that boosting VEGF expression around follicles led to faster hair regrowth and thicker hair shafts, while blocking VEGF slowed growth and produced smaller follicles.⁹

As follicles miniaturize in balding areas, their growth phases shorten and the demand signal for new blood vessels weakens. Fewer blood vessels form, which means less oxygen and fewer nutrients reach the follicle, which further compromises its ability to produce a robust hair. The scalp on top of the head, already anatomically distinct from the well-muscled and well-perfused sides, may be more vulnerable to this decline in vascular support. Reduced blood flow doesn’t initiate baldness on its own, but it accelerates the process once miniaturization is underway.

The Stem Cells Are Still There

One of the more surprising discoveries in hair-loss research is that even completely bald scalp retains its hair follicle stem cells. The reservoir of stem cells in the follicle’s bulge region persists in bald skin. What’s missing is the next step in the pipeline: the progenitor cells that stem cells normally generate to build a new hair.¹⁰

Research on balding scalp tissue has confirmed this picture: partially bald areas still contain progenitor cells expressing key markers, but completely bald areas have lost them.¹¹ The implication is both frustrating and hopeful. Frustrating because the machinery for hair growth is broken at a specific step in the chain. Hopeful because the stem cells are still alive, meaning that if researchers can figure out how to reactivate the conversion of stems into progenitors, regrowth from bald scalp might theoretically be possible. This is a fundamentally different situation from scarring alopecia, where the stem cells themselves are destroyed. In androgenetic alopecia, the factory is intact but its assembly line is jammed.

Genetics Set the Stage

The tendency to go bald is strongly heritable, but the genetics are complex. There is no single “baldness gene.” A large genome-wide study identified numerous genetic variants scattered across many chromosomes, including the X chromosome (which you inherit from your mother), that collectively influence your risk. Using combined genetic scores from autosomal and X-chromosome variants, researchers could predict severe hair loss with reasonable accuracy, but prediction grew weaker for milder degrees of thinning.¹²

This explains why the old folk wisdom about looking at your mother’s father to predict your hair future is partly right but far from the full story. Yes, the androgen receptor gene sits on the X chromosome, so variants there are inherited from your mother’s side. But dozens of other risk variants are on non-sex chromosomes and can come from either parent. You can have a bald father and keep your hair, or have a full-haired father and lose yours, because the genetic contribution is spread across the genome. The X-chromosome signal is the strongest single contributor, but it’s one voice in a large choir.

Why Women Lose Hair Differently

Women experience androgenetic alopecia too, but the pattern is usually different. Instead of the receding temples and bald crown that characterize male-pattern loss, women more commonly develop diffuse thinning across the top of the scalp while the frontal hairline stays relatively intact. The underlying hormonal mechanism is similar (DHT-driven follicular miniaturization), but differences in hormone levels, enzyme distribution, and receptor expression create a different geographic pattern of thinning.

Treatment approaches reflect these differences. Men are typically prescribed 5-alpha reductase inhibitors like finasteride, which block the conversion of testosterone to DHT, along with minoxidil. Women, in whom systemic DHT-blocking drugs carry different risk profiles, are more often treated with minoxidil and antiandrogens such as spironolactone. Combination approaches are common for both sexes, and meaningful improvement generally requires at least six months of consistent treatment.¹³

What Current Treatments Actually Target

The two longstanding pharmacological options for male-pattern hair loss each attack a different part of the problem. Finasteride inhibits the enzyme that produces DHT, reducing DHT levels and slowing follicular miniaturization. Minoxidil, originally developed as a blood pressure medication, works through a different route: it enhances blood flow around follicles, prolongs the growth phase of the hair cycle, and promotes thicker hair shafts.¹⁴ Neither drug reverses advanced baldness completely, but both can slow progression and partially restore density, especially when started early. The earlier in the process you intervene, while follicles are still miniaturized rather than fully dormant, the better the response tends to be.

Hair transplant surgery takes advantage of the regional biology discussed earlier. Follicles harvested from the androgen-resistant back of the head are relocated to the thinning crown or temples, where they continue to grow as they did in their original location. The transplanted follicles retain their donor-site genetics, so they resist the DHT that destroyed their neighbors. Newer research directions aim at the stem-cell-to-progenitor bottleneck, attempting to reawaken the dormant machinery in bald scalp rather than importing new follicles. That work remains experimental, but it’s driven by the encouraging finding that the stem cells themselves survive even in completely bald skin.

Evolutionary Speculations

Given how common male-pattern baldness is, and how strongly genetic it appears to be, evolutionary biologists have wondered why natural selection hasn’t eliminated it. Several hypotheses have been proposed, none of them definitive. One idea frames baldness as a signal of social maturity and a non-threatening form of dominance, suggesting that bald or balding men may have been perceived as wise and nurturing rather than aggressive, which could have carried social advantages in group settings.¹⁵

A different hypothesis turns the lens toward mate selection, suggesting that visible hair loss may have helped women identify and prefer younger adult males as mates. Since conceptions by younger fathers are statistically more likely to result in live births and healthier offspring, hair loss serving as an age marker could have improved reproductive outcomes at the population level, even at a cost to the individual losing his hair.¹⁶ Both proposals are speculative, and it’s equally possible that baldness is simply not costly enough to survival or reproduction to be selected against with any force, persisting as a neutral byproduct of androgen biology that evolution had no reason to fix.

Animal Models and What They Reveal

Humans aren’t the only primates that go bald in a predictable pattern. The stumptailed macaque develops hair loss on the crown after puberty in a pattern that closely resembles human androgenetic alopecia, driven by the same post-pubertal rise in testosterone and DHT.¹⁷ These macaques have been used for decades to test potential hair-loss treatments, including prostaglandin analogs originally developed for glaucoma that were noticed to promote eyelash growth as a side effect.¹⁸ The fact that another primate species develops the same region-specific, hormone-driven pattern of hair loss reinforces that the phenomenon is deeply rooted in primate biology, not a quirk of modern human life. It also means that whatever developmental programming makes the crown vulnerable to androgens likely predates the split between human and macaque lineages millions of years ago.